Cargando…
Parkinson's disease and mitophagy: an emerging role for LRRK2
Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects around 2% of individuals over 60 years old. It is characterised by the loss of dopaminergic neurons in the substantia nigra pars compacta of the midbrain, which is thought to account for the major clinical symptom...
Autores principales: | Singh, Francois, Ganley, Ian G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106497/ https://www.ncbi.nlm.nih.gov/pubmed/33769432 http://dx.doi.org/10.1042/BST20190236 |
Ejemplares similares
-
Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice
por: Singh, Francois, et al.
Publicado: (2021) -
Impact of Type II LRRK2 inhibitors on signaling and mitophagy
por: Tasegian, Anna, et al.
Publicado: (2021) -
Strengthening the link between mitophagy and Parkinson’s
disease
por: Ganley, Ian G
Publicado: (2022) -
Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson’s disease models
por: Williamson, Matthew G, et al.
Publicado: (2023) -
The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)